<DOC>
	<DOCNO>NCT01370343</DOCNO>
	<brief_summary>The primary purpose study evaluate pharmacokinetics , safety tolerability single dose PF-04991532 healthy adult subject without co-administration cyclosporine .</brief_summary>
	<brief_title>Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Healthy male and/or female ( nonchildbearing potential ) subject age 18 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test . Women must non childbearing potential defined Lifestyle Guidelines . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . An informed consent document sign date subject legally acceptable representative . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , sychiatric , neurologic , allergic ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) disease clinical finding Screening . Subjects clinically significant infection within past 3 month ( example , require hospitalization , judge Investigator ) , evidence infection within past 7 day . Screening supine blood pressure &gt; =140 mm Hg ( systolic ) &gt; =90 mm Hg ( diastolic ) , single measurement [ confirm single repeat , necessary ] follow least 5 minute rest .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>